Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2013-02-28 | BL-9010 | asthma |
preclinical | BioLineRx (Israel) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
2013-02-26 | trabedersen | high-grade brain tumors (recurrent or refractory anaplastic astrocytoma or secondary glioblastoma) | 3 | Antisense Pharma, now Isarna Therapeutics(Germany) | Cancer - Oncology |
2013-02-26 | trabedersen | advanced pancreatic cancer malignant melanoma colorectal cancer |
1-2 | Antisense Pharma, now Isarna Therapeutics (Germany) | Cancer - Oncology |
2013-02-25 | vaccine against respiratory syncytial virus | respiratory syncytial virus (RSV) infections | 1 | Okairos (Italy) | Infectious diseases |
2013-02-25 | ToleroMune® cat allergy Vaccine | cat allergy |
2 | Circassia (UK) | Allergic diseases - Immunogical diseases |
2013-02-24 | omalizumab | moderate to severe refractory chronic idiopathic/spontaneous urticaria (CIU/CSU) |
3 | Novartis (Switzerland) Genentech, a member of Roche group (USA - Switzerland) | Dermatological diseases - Inflammatory diseases |
2013-02-21 | AllerR | allergy to ragweed pollen |
preclinical | Anergis (Switzerland) | Allergic diseases - Immunological diseases |
2013-02-21 | MYM-V101 | HIV/Aids | 1 | Mymetics (Switzerland) | Infectious diseases |
2013-02-20 | PA401 | inflammatory lung disease |
1 | ProtAffin (Austria) | Inflammatory diseases - Lung diseases - Rare diseases - Genetic diseases |
2013-02-18 | ConfirmMDx™ for Prostate Cancer | prostate cancer | MDxHealth (Belgium) | Cancer - Oncology | |
2013-02-18 | piromelatine | insomnia | 2 | Neurim Pharmaceuticals (Israel - Switzerland) | CNS diseases |
2013-02-18 | Cogane™ (smilagenin) | Parkinson\'s disease | 2 | Phytopharm (UK) | Neurodegenerative diseases - CNS diseases |
2013-02-15 | NT-KO-003 | multiple sclerosis | 2a | Advancell (Spain) Neurotec Pharma (Spain) | Autoimmune diseases - Neurodegenerative diseases |
2013-02-14 | recombinant human Nerve Growth Factor (rhNGF) | neurotrophic keratitis |
1-2 | Dompé (Italy) | Ophtalmological diseases |
2013-02-14 | adult stem-cells derived from bone-marrow | diabetic retinopathy | preclinical | Centre for Vision and Vascular Science (CVVS) at Queen’s University Belfast (Ireland) | Ophtalmological diseases |
2013-02-14 | NiCord® (expanded cell graft derived from an entire unit of umbilical cord blood enriched with stem cells) | sickle cell disease | 1-2 | Gamida Cell (Israel) | Genetic diseases - Blood diseases |
2013-02-12 | CP024 (nasal formulation of human growth hormone [hGH]) | growth disorders | 1 | Critical Pharmaceuticals (UK) | Hormonal diseases - Endocrine diseases |
2013-02-12 | masitinib in combination with FOLFIRI | metastatic colorectal cancer (mCRC) in first relapse | 3 | AB Science (France) | Cancer - Oncology |
2013-02-11 | ularitide | acute heart failure |
3 | Cardiorentis (Switzerland) | Cardiovascular diseases |
2013-02-11 | romosozumab (CDP7851/AMG 785) | acceleration of fracture healing | 3 | UCB (Belgium) Amgen (USA - CA) | Bone diseases |